Skip to main content
PLOS One logoLink to PLOS One
. 2024 Aug 13;19(8):e0304829. doi: 10.1371/journal.pone.0304829

Prevalence and associated factors of non-communicable chronic diseases among university academics in Jordan

Abdullah M Khamaiseh 1,*, Sakhaa S Habashneh 2
Editor: Ala’a B Al-Tammemi3
PMCID: PMC11321547  PMID: 39137231

Abstract

The increasing prevalence of non-communicable chronic diseases on a global, regional, and local scale demonstrates the extensive impact of these diseases, which now account for 70% of all worldwide deaths and affect a diverse population outside affluent places. The purpose of this study was to assess the prevalence and associated factors of non-communicable chronic diseases among academics at Mutah University in Jordan, while also taking into account the global trend of non-communicable diseases impacting different demographics. In a cross-sectional study, the majority of faculty members completed a questionnaire that included demographic information and prevalence of chronic diseases. The most prevalent conditions detected were hypertension (19.6%), diabetes mellitus (17.5%), rheumatoid arthritis (14.2%), heart disease (12.6%), and respiratory disorders (11.3%). Specifically, smoking and being overweight are underlined as significant risk factors, particularly among male respondents. These findings highlight the need of implementing health promotion programs in educational academic institutions, with an emphasis on fostering healthy dietary habits and encouraging physical activity.

Introduction

The prevalence of non-communicable chronic diseases (NCCDs), which are defined as irreversible pathological alterations affecting particular body systems, has increased globally and is a problem for both developed and developing countries [1].

Almost 70% of deaths worldwide are caused by NCCDs [25], with more than 35 million deaths yearly, most of which take place in low- and middle-income countries [6, 7]. These diseases not only lead to functional impairments but also present personal, economic, and social challenges [8]. NCCDs, which account for more than two-thirds of all deaths in the US, are the main causes of mortality, including diabetes, cancer, and cardiovascular diseases [9].

Compelling scientific data indicates a substantial correlation between the occurrence of cancer, cardiovascular disease, chronic respiratory illness, and diabetes and modifiable risk factors. Alcohol intake, obesity, cigarette smoking, unhealthy diet, and physical inactivity all contribute to more than two-thirds of the incidences of these diseases [10].

The prevention and management of NCCDs frequently rely on behavioral interventions, including promoting healthy diet, encouraging higher levels of physical activity, and discouraging unhealthy behaviors such as tobacco use and alcohol use [11].

In Jordan, NCCDs are the primary cause of morbidity and mortality, accounting for 76% of total deaths [12, 13]. Diabetes is prevalent among Jordanians aged 25 and up, accounting for 34% of the population. Furthermore, it was anticipated that the prevalence of chronic diseases in Jordan will quickly increase between 2005 and 2050 [14]. Population-based data on the prevalence of NCCDs is critical for establishing effective preventative and management strategies [11]. Addressing NCCDs and their underlying causes in early adulthood can have a role in delaying disease progression and increasing general well-being throughout an individual’s lifespan [15]. NCCDs have a disproportionate impact on the older population worldwide. Statistics show that 80% to 92% of older persons have at least one NCCD, and 50% to 77% have two or more. Cardiovascular disease, chronic obstructive pulmonary disease, and diabetes are the most common non-communicable diseases among the elderly [16].

Significance of the study

Health and quality of life are greatly impacted worldwide by NCCDs [9]. The increasing prevalence in low and middle-income countries requires immediate attention and a comprehensive response from policymakers and the international public health community [17]. Despite the widespread belief that university academics generally maintain good health [18], Being a researcher training nursing students in hospitals and medical centers exposed a different reality. Academic colleagues regularly receiving monthly medications for various NCCDs were consistently observed. As an associate professor employed in a health faculty, this observation motivates to initiate a study on the health status of academics in similar environments. Consequently, the purpose of this study is to assess the NCCDs and associated factors among academic staff at Mutah University in Jordan. The findings aim to offer valuable insights for intervention planning and stakeholder engagement.

Literature review

NCCDs, which contribute significantly to morbidity and mortality globally, are a major health concern [1921]. Lifestyle and dietary changes have made these conditions a major public health issue [22]. Cardiovascular diseases, malignancies, respiratory illnesses, and diabetes are significant NCCDs that are influenced by risk factors such as poor diet, insufficient physical activity, and tobacco use [23]. Preventable risk factors, such as smoking, hypertension, overweight, high cholesterol, alcohol consumption, and improper diet, lead to a significant percentage of NCCDs [20].

In the Eastern Mediterranean Region (EMR), which includes Jordan, NCCDs represent a considerable burden, with mortality rates exceeding those of communicable diseases by more than ten times [24].

Prevalence of NCCDs and main risk factors in Jordan

Jordan is undergoing an epidemiological shift, with chronic diseases becoming increasingly prevalent. Among Jordanian youths, sedentary lifestyles, poor dietary habits, and smoking are commonly observed health risks. The prevalence of smoking among Jordanian patients with chronic diseases ranges between 21% and 27%, and chronic diseases account for the vast majority of deaths in Jordan. Heart disease and stroke are responsible for more than 30% of these deaths [25]. In comparison to communicable diseases, the mortality rate from non-communicable diseases in Jordan is nearly 15.5 times higher [25]. These findings highlight the urgent need for preventive measures and comprehensive interventions in the region.

Research questions

This study aimed to address the following research questions:

What was the prevalence rate of key NCCDs observed within the academics at Mutah University?

What were the factors associated with the primary NCCDs identified among the academic community at Mutah University?

Materials and methods

Design and settings

The aim of this study was to assess NCCDs and their associated factors among academic’s members at Mutah University in Jordan. To achieve this, a cross-sectional design was utilized to examine the prevalence and determinants of NCCDs among academic staff at Mutah University. The research was carried out at Mutah University encompassing all 15 faculties.

The faculties are categorized into four health-related faculties and eleven non-health related faculties.

Study participants

The faculty at Mutah University comprises 626 members, contributing to the academic and research endeavors of the institution. The participants in this study comprised the entire academic staff of Mutah University who voluntarily expressed their willingness to participate during the data collection period. The inclusion criteria for the study were as follows:

  1. Academic Status: All participants must be currently serving as academic staff at Mutah University.

  2. Employment Status: Participants must be employed on a full-time basis.

  3. Gender: Both male and female academic staff were eligible for inclusion.

  4. Nationality: The study included participants of all nationalities.

  5. Consent: Informed consent was a prerequisite for participation in the study.

Study instrument

The questionnaire employed in the study encompasses two sections:

  1. Demographic Information: This part gathers fundamental demographic details from participants, including age, gender, weight, height, marital status, education level, academic rank, and faculty affiliation.

  2. Sample Questionnaire for NCCDs: The subsequent section adopts the Sample Questionnaire for Chronic Disease crafted by the Stanford Patient Education Research Center. This standardized tool gauges the health status of individuals grappling with chronic illnesses across six primary domains:
    • a)
      General Health: This section typically probes into participants’ perceptions of overall health, quality of life, experienced symptoms, and any constraints imposed by health conditions.
    • b)
      Physical Activities: Queries within this category delve into the frequency, duration, and intensity of participants’ physical activities, offering insights into their exercise habits.
    • c)
      Confidence in Task Performance: This component evaluates participants’ confidence levels in executing various tasks pertinent to managing their health condition, such as adhering to treatment plans, coping with symptoms, and communicating effectively with healthcare providers.
    • d)
      Daily Activities: Questions here explore how NCCDs impacts participants’ daily routines, encompassing work, household chores, social engagements, and recreational pursuits.
    • e)
      Medical Care: This segment assesses participants’ satisfaction with the medical care they receive, their access to healthcare services, the quality of communication with healthcare providers, and their overall healthcare experiences.

The Sample Questionnaire for NCCDs from the Stanford Patient Education Research Center typically comprises multiple-choice queries, Likert scale items, and open-ended questions. Response options span a spectrum from "strongly agree" to "strongly disagree," aiming to capture a broad range of experiences related to living with NCCDs, including physical well-being, emotional health, functional abilities, and interactions with healthcare services. Utilizing this standardized tool allows for comparability with other studies using similar instruments, contributing to a broader understanding of NCCDs across diverse populations. All the original questionnaire items from Stanford Patient Education Research Center used in the data collection. However, as the focus of this manuscript was solely on questions that were directly relevant to the research title, objectives, and questions, certain items were overlooked by data analysis.

Instrument validity

The questionnaire was subjected to a validity assurance method that includes translation into Arabic by an experienced professional translator with extensive experience translating healthcare and medical research content. This translator displayed a high level of expertise in understanding the terminology and concepts pertaining to healthcare and related sectors contained within the questionnaires, followed by back translation into English. A comprehensive comparison of the post-translated English version and the original confirmed that they were identical. In addition, a pilot study was carried out with 30 faculty members. The goal was to determine the feasibility of the study protocol, ensure the questionnaire’s comprehensiveness, confirm the clarity and consistency of the questions, and make any required changes to the questionnaire’s language. It’s important to highlight that the findings of the pilot study were not incorporated into the present study.

Procedure

The Stanford Patient Education Research Center provided permission to utilize the complete questionnaire or any of its portions without fee. Before beginning data collection and after receiving official consent from the university administration, extensive briefings were held with deans and department heads from each selected faculty to cover all aspects of the study. They received questionnaires, information sheets, letters of ethical approval, and permission forms. Six research assistants were recruited and trained prior to the start of the study to help with the research. The responsibilities of the research assistants included distributing questionnaires, addressing queries, and providing support to participants who needed assistance in completing the questionnaires. Subsequently, the research assistants collected the completed questionnaires and handed them over to the researchers. The data collection phase extended for a month, starting on Sunday, February 5, 2023, and concluding on Sunday, March 5 of the same year.

Ethical approval

The study adhered to the principles expressed in the Declaration of Helsinki and received approval from the Faculty of Nursing’s Institutional Review Board under Proposal No. EC2/2018, in accordance with Mutah University’s ethical norms. Participants were given an Arabic-language consent form that outlined the study’s aims, guaranteed anonymous data collection, and ensured the highest level of confidentiality. Participation in the study was voluntary, and staff members were encouraged to signify their consent through both formal written and informal verbal channels.

Statistical analysis

Data analysis was performed using IBM SPSS Statistics for Windows, version 25.0, developed by IBM Corp. Descriptive statistics, such as frequencies, percentages, means, and standard deviation, were employed to present the demographic characteristics of the participants. Furthermore, inferential statistics were applied, utilizing the chi-square test, with significance set at the 0.05 level.

Results

A total of 412 questionnaires were distributed to participants who met the eligibility criteria in the various faculties, that two hundred and forty-one (241) questionnaires were completed and returned to the researcher, yielding a response rate of 58%.

The results comprised demographic characteristics, the prevalence of NCCDs, and factors associated with these NCCDs.

Demographic characteristics of the study participants

Table 1 outlines the demographic information of the 241 academics who took part in the study. A significant majority of the participants were male (n = 189; 78.4%). The mean age of the study participants was 44.50±9.60 years, covering an age range from 25 to 70 years. Almost half of the participants were in the age bracket of 41 to 60 years, and around one-third held the role of assistant professor. The prevailing marital status among the subjects was married, accounting for 89.6% of the participants.

Table 1. Participants demographic characteristics.

Variable Gender Total P- Value
Male Female
Age N (%) N (%) 0.000
20–30 5(2.1) 8(3.3) 13(5.4)
31–40 55(23) 27(11.3) 82(34.3)
41–60 104(43.5) 15(6.3) 119(49.8)
>60 23(9.6) 2(0.8) 25(10.4)
Rank
Full prof 56(23.2) 4(1.7) 60(24.9) 0.000
Associate prof 47(19.7) 5(2.1) 52(21.8)
Assistant Prof 60(25.1) 19(7.9) 80(33.0)
Teacher 14(5.9) 8(3.3) 22(9.2)
Clinical Instructor 3(1.2) 3(1.2) 6(2.5)
Bachelor 7(2.9) 14(5.8) 21(8.7)
Marital status
Married 178(74.2) 37(15.8) 215(89.6) 0.000
Single 8(3.3) 14(5.8) 22(9.2)
Divorced 1(0.4) 1(0.4) 2(0.8)
Widowed 1(0.4) 0(0.0) 1(0.4)
Faculty
Health faculties 86(37.2) 15(6.5) 101(43.7) 0.037
Non health faculties 96(41.6) 34(14.7) 130(56.3)

As shown in Fig 1. Hypertension (19.6%), diabetes mellitus (DM) (17.5%), rheumatic arthritis (14.2%), cardiac diseases (12.6%), and respiratory disorders (11.3%) were the most common Non-Communicable Diseases(NCCDs) among academics. Male academics exhibited a higher prevalence of these five NCCDs compared to their female counterparts.

Fig 1. Prevalence of chronic diseases among the participants.

Fig 1

Hypertension(HTN) (19.6%), diabetes mellitus (DM) (17.5%), rheumatic arthritis (14.2%), cardiac diseases (12.6%), and respiratory disorders (11.3%) were the most common Non-Communicable Chronic Diseases (NCCDs) among academics. Male academics exhibited a higher prevalence of these five NCCDs compared to their female counterparts.

Fig 2 illustrates that the rating scale ranged from "None"(0) to Severe pain (7–10). Approximately 62.5% of the academics noted their typical pain interfering with their activities as mild, followed by 27.6% experiencing moderate pain, 5.5% experiencing severe pain, and 4.3% reporting no pain.

Fig 2. The Numeric Pain Rating Scale (NPRS).

Fig 2

The rating scale ranged from "None" (0) to "Severe pain" (7–10). Approximately 62.5% of the academics noted their typical pain interfering with their activities as mild, followed by 27.6% experiencing moderate pain, 5.5% experiencing severe pain, and 4.3% reporting no pain.

According to Fig 3, approximately half of the participants (53.1%) viewed their health status as very good, 22.2% as excellent, and 21.8% as good, with only 2.9% describing their health as fair.

Fig 3. Academics health perception.

Fig 3

Approximately half of the participants (53.1%) viewed their health status as very good, 22.2% as excellent, and 21.8% as good, with only 2.9% describing their health as fair.

Prevalence of risk factors among participants according to gender

Regarding the associated risk factors, the data in Table 2 showed that 12.3% of men and 2.6% of women were obese, while 44.9% of men and 9.3% of women were overweight. Smoking prevalence is much higher among men than women (32.7,1.8 respectively). Table 2 also displays that 15% of men and 3.4% were never performing walking exercises during the last week of the study. It is noteworthy that individuals who answered the question expressed that walking more than three hours a week, is considered regular walking Finally, just as men were more than women in the prevalence of NCCDs, the same situation with regard to risk factors.

Table 2. Prevalence of risk factors among participants according to gender.

Risk factor Male Female Total P-value
Obesity 28(12.3) 6(2.6) 34(14.9) .009
Overweight 102(44.9) 21(9.3) 123(54.2) .009
Never walking regularly 35(15) 8(3.4) 43(18.4) .0966
Smoking 74(32.7) 4(1.8) 78(34.5) 0.000

Discussion

The purpose of this cross-sectional study was to assess the prevalence of NCCDs and associated factors among the university’s academic staff. There is no literature on academics to which the findings of this study can be compared. As a result, the comparison was made with different populations described in previous studies.

Among the 241 participants, the study revealed that the most prevalent NCCDs among academics were hypertension (19.6%), diabetes mellitus (17.5%), rheumatoid arthritis (14.2%), cardiac diseases (12.6%), and respiratory disorders (11.3%). These findings are consistent with a study conducted in Addis Ababa, where chronic arthritis, hypertension, and diabetes mellitus were reported as the most common diseases among participants [6]. In contrast, the prevalence in our study is lower than a study in Saudi Arabia, where 71.3% had hypertension, 27.3% had diabetes, 16.4% had heart disease, and 9.7% had asthma. This difference may be attributed to cultural, custom, and lifestyle disparities between the two countries. Additionally, the variation could be influenced by the different levels of education, as our study focused on academics, while the Saudi study included adults in general. A study in Amman, Jordan, aimed at identifying individuals at elevated risk of developing type 2 diabetes, reported that 37% of participants had hypertension, and 28% had diabetes mellitus [26]. The higher prevalence in the Jordanian study might be associated with a genetic factor, considering that more than two-thirds of the participants had a direct relative diagnosed with diabetes. Our study indicated lower rates of hypertension and diabetes compared to a study in Palestine, where cardiovascular disease prevalence was 28.4% and 19.1%, respectively [27]. The prevalence of heart disease was also lower in our study (8.3% compared to 12.6%).

Furthermore, the prevalence of hypertension in our study is lower than in studies conducted in Swaziland and Saudi Arabia, where rates were 48.3% and 39.2%, respectively [3, 28]. Alshloul suggested that individuals with higher education levels, such as doctorate and master holders, may have lower vulnerability to hypertension due to increased awareness of healthy lifestyle practices [28].

A recent study in Jordan aimed to evaluate the prevalence of obesity among Jordanian women and its relationship with several NCCDs. The findings revealed that 59.8% of participants reported arthritis-related pain. However, the most frequent NCCDs observed were hypertension (29.5%), followed by diabetes and hypertriglyceridemia to a lesser extent [14].

Addressing obesity as a significant risk factor, our study revealed a general prevalence of obesity and overweight at 14.9% and 54.2%, respectively. These findings differ from a study in the UAE, where the prevalence of overweight and obesity was 43.0% and 32.3%, respectively [29]. Differences in study populations and education levels could contribute to these variations. The prevalence of overweight and obesity is increasing globally, both in developed and developing countries. Obesity rates were recorded at 46% in Kuwait, 35% in the UAE, and 34% in Bahrain [30]. Maintaining a healthy body weight is critical for avoiding the health concerns associated with overweight and obesity, thereby lowering both morbidity and mortality [30]. Our study found that males were more likely than females to be overweight or obese.

Regarding smoking prevalence, our study showed that 32.7% of males and 1.8% of females reported smoking. This contrasts with a study in Jordan, where the overall prevalence of cigarette smoking was 59.1% among males and 23.3% among females [31]. In Jordanian society, smoking is more commonly accepted among men than women, often due to societal ideals of masculinity and femininity. Smoking might signify status or defiance for men, whereas women often encounter greater social disapproval. Furthermore, variances in health behaviors between genders are influenced by upbringing, healthcare accessibility, and individual perceptions of health risks. Men and women may have different coping strategies for stress and levels of readiness to get help quitting smoking. Furthermore, creating health initiatives that are individually aimed at each gender may have different results in terms of smoking behaviors. Cultural norms that discourage women from smoking may have contributed to the decreased frequency among Jordanian women in our study [32], and female participants might provide false information in their responses.

Our study revealed that 81.6% of academic staff members walk regularly—that is, they walk for more than three hours a week—despite their busy schedules, which include teaching, research, administrative work, and other responsibilities.

This rate exceeds the 12.5% reported in a national study in Jordan [33], reflecting a higher level of physical activity among academics. This increased activity could be due to their understanding of its role in preventing NCCDs. Furthermore, the availability of suitable facilities and walking paths on campus may contribute to this elevated level of physical activity among academics. Regular physical activity is recognized as a healthy behavior that reduces the risk of NCCDs [33].

Limitations

This research takes the form of an observational cross-sectional study, which poses challenges in establishing causal relationships with NCCDs. Moreover, Recognizing the constraints of subjective questionnaire items and the biases they might bring forth allows researchers to actively refine research methodologies. This understanding can motivate future investigations to seek alternative strategies, like mixed methods research or triangulating data sources, in order to mitigate subjectivity’s impact and improve the validity of research outcomes. Moreover, there is no literature specifically on academics to compare the results of this study with. Therefore, the comparison applied with various populations reported in other studies means that the findings of this study do not necessarily representative to all academics in Jordan’s public universities.

Implications

Studying the prevalence and associated factors of NCCDs among university academics in Jordan holds significant implications for health professions across education, practice, and research.

In education, understanding the prevalence and contributors to NCCDs can raise awareness among students and faculty about preventive health measures. This knowledge can be integrated into curricula, focusing on lifestyle medicine, preventive care, and occupational health, tailored to university settings. Additionally, promoting healthy habits and offering regular health screenings can be part of educational initiatives.

In practice, universities can establish occupational health programs to address academics’ specific health needs, including health screenings, ergonomic assessments, and mental health support. Health promotion initiatives, such as wellness programs and access to fitness facilities, can be implemented, fostering multidisciplinary collaboration among healthcare professionals, educators, and administrators.

In research, investigating the risk factors contributing to NCCDs among academics can inform tailored interventions. Intervention studies can evaluate the effectiveness of strategies like lifestyle interventions and workplace wellness programs. Longitudinal studies tracking health outcomes can provide insights into the trajectory of NCCDs and the efficacy of interventions.

In summary, understanding NCCDs among university academics in Jordan can guide educational efforts, practice guidelines, and research agendas. By integrating this knowledge, implementing targeted interventions, and conducting research, health professions can contribute to promoting the health and well-being of academics and reducing the burden of NCCDs in this population.

Conclusions

The most prevalent NCCDs among academics were hypertension, Diabetes Mellitus, Rheumatoid arthritis, Cardiac diseases, and respiratory disorders. Men exhibited higher rates of overweight and smoking compared to women, posing significant risk factors. Implementing wellness initiatives within universities that encourage healthy lifestyle choices, including proper dietary habits and regular physical activity, is strongly recommended. Additionally, offering health promotion programs that address modifiable risk factors such as smoking, screening for common NCCDs, and providing treatment and follow-up for affected individuals are essential to mitigate the impact of these diseases. Nevertheless, it is crucial to conduct future analytical epidemiological studies to thoroughly investigate the prevalence and risk factors of NCCDs among academics. Specific suggestions for future research and interventions aimed at promoting health and reducing NCCDs rates among academic staff could include conducting longitudinal studies to evaluate the impact of workplace wellness programs tailored to this population. Additionally, implementing educational workshops focusing on nutrition and stress management, along with incorporating regular physical activity breaks into the daily work schedule, presents promising strategies for exploration and implementation. These targeted initiatives not only have the potential to enhance the health and well-being of academic staff but also to cultivate a supportive and health-conscious work environment.

Supporting information

S1 File. Stanford patient education questionnaire.

(PDF)

pone.0304829.s001.pdf (150.6KB, pdf)
S2 File. Arabic study questionnaire.

(DOC)

pone.0304829.s002.doc (93KB, doc)
S3 File. English Study questionnaire.

(DOC)

pone.0304829.s003.doc (155.5KB, doc)

Acknowledgments

The researchers would like to express their heartfelt gratitude to the university administration, Faculties deans, and department heads for their assistance in gathering data, as well as to all the academics who took part in the study.

Data Availability

All relevant data are within the manuscript and its Supporting information files.

Funding Statement

The author(s) received no specific funding for this work.

References

  • 1.Rohde JA, Noar SM, Horvitz C, Lazard AJ, Cornacchione Ross J, Sutfin EL. The role of knowledge and risk beliefs in adolescent e-cigarette use: A pilot study. International journal of environmental research and public health. 2018;15(4):830. doi: 10.3390/ijerph15040830 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.El-Saadani SM, Saleh MM, Ibrahim SA. Quantifying non-communicable diseases’ burden in Egypt using State-Space model. medRxiv. 2021. doi: 10.1371/journal.pone.0245642 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Liyanage IK, Wickramasinghe K, Katulanda P, Jayawardena R, Karunathilake I, Friel S, et al. Integrating the development agenda with noncommunicable disease prevention in developing countries: a quasi-experimental study on inter-sectoral action and its impact on self-reported salt consumption—the INPARD study. Cardiovascular diagnosis and therapy. 2019;9(2):120. doi: 10.21037/cdt.2018.10.19 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Ajlouni K, Khader Y, Alyousfi M, Al Nsour M, Batieha A, Jaddou H. Metabolic syndrome amongst adults in Jordan: prevalence, trend, and its association with socio-demographic characteristics. Diabetology & Metabolic Syndrome. 2020;12(1):1–11. doi: 10.1186/s13098-020-00610-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Bonilla-Sierra P, Vargas-Martínez A-M, Davalos-Batallas V, Leon-Larios F, Lomas-Campos M-d-l-M. Chronic diseases and associated factors among older adults in Loja, Ecuador. International Journal of Environmental Research and Public Health. 2020;17(11):4009. doi: 10.3390/ijerph17114009 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Woldesemayat EM, Kassa A, Gari T, Dangisso MH. Chronic diseases multi-morbidity among adult patients at Hawassa University Comprehensive Specialized Hospital. BMC public health. 2018;18(1):352. doi: 10.1186/s12889-018-5264-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Alzeidan R, Rabiee F, Mandil A, Hersi A, Fayed A. Non-communicable disease risk factors among employees and their families of a Saudi university: an epidemiological study. PloS one. 2016;11(11):e0165036. doi: 10.1371/journal.pone.0165036 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Maresova P, Javanmardi E, Barakovic S, Barakovic Husic J, Tomsone S, Krejcar O, et al. Consequences of chronic diseases and other limitations associated with old age–a scoping review. BMC public health. 2019;19:1–17. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Hoffman D. Commentary on chronic Disease Prevention in the US in 2022. Ann Bioeth Clin App. 2022;5(2):10.23880. [Google Scholar]
  • 10.Ng R, Sutradhar R, Yao Z, Wodchis WP, Rosella LC. Smoking, drinking, diet and physical activity—modifiable lifestyle risk factors and their associations with age to first chronic disease. International journal of epidemiology. 2020;49(1):113–30. doi: 10.1093/ije/dyz078 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Airhihenbuwa CO, Tseng T-S, Sutton VD, Price L. Non–Peer Reviewed: Global Perspectives on Improving Chronic Disease Prevention and Management in Diverse Settings. Preventing Chronic Disease. 2021;18. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Al-Nsour M, Zindah M, Belbeisi A, Hadaddin R, Brown DW, Walke H. Prevalence of selected chronic, noncommunicable disease risk factors in Jordan: results of the 2007 Jordan Behavioral Risk Factor Surveillance Study. Preventing chronic disease. 2012;9. [PMC free article] [PubMed] [Google Scholar]
  • 13.Walke H, Mokdad AH, Zindah M, Belbeisi A. Peer Reviewed: Obesity and Diabetes in Jordan: Findings From the Behavioral Risk Factor Surveillance System, 2004. Preventing chronic disease. 2008;5(1). [PMC free article] [PubMed] [Google Scholar]
  • 14.Bustami M, Matalka KZ, Mallah E, Abu-Qatouseh L, Abu Dayyih W, Hussein N, et al. The prevalence of overweight and obesity among women in Jordan: a risk factor for developing chronic diseases. Journal of Multidisciplinary Healthcare. 2021:1533–41. doi: 10.2147/JMDH.S313172 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Watson KB, Carlson SA, Loustalot F, Town M, Eke PI, Thomas CW, et al. Chronic conditions among adults aged 18–34 years—United States, 2019. Morbidity and mortality weekly report. 2022;71(30):964. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Abdalla AG, El-Hady A, Said F, Sedky S, Mohammed NA. Health indicators among elderly people with chronic diseases in Beni-Suef. NILES journal for Geriatric and Gerontology. 2022;5(1):126–50. [Google Scholar]
  • 17.Hvidberg MF, Johnsen SP, Davidsen M, Ehlers L. A nationwide study of prevalence rates and characteristics of 199 chronic conditions in Denmark. PharmacoEconomics-open. 2020;4(2):361–80. doi: 10.1007/s41669-019-0167-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Raghupathi V, Raghupathi W. The influence of education on health: an empirical assessment of OECD countries for the period 1995–2015. Archives of Public Health. 2020;78:1–18. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Kahraman M, Kahraman S. Prevalence of Chronic Diseases Among Elementary School Students in Şanlıurfa, Turkey. Istanbul Medical Journal. 2023;24(2). [Google Scholar]
  • 20.Jennings SM. Preventing chronic disease: defining the problem. 2014.
  • 21.Lee M, Park S, Lee K-S. Relationship between morbidity and health behavior in chronic diseases. Journal of clinical medicine. 2020;9(1):121. doi: 10.3390/jcm9010121 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Ahmed W, Muhammad T, Muneera K. Prevalence of early and late onset of chronic diseases and multimorbidity and its association with physical, mental and functional health among older Indian adults. BMC geriatrics. 2023;23(1):563. doi: 10.1186/s12877-023-04264-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Bortkiewicz A, Szyjkowska AM, Siedlecka J, Makowiec-Dąbrowska T, Gadzicka E. Selected chronic diseases and their risk factors in teachers. Medycyna Pracy. 2020;71(2):221–31. [DOI] [PubMed] [Google Scholar]
  • 24.Rehr M, Shoaib M, Ellithy S, Okour S, Ariti C, Ait-Bouziad I, et al. Prevalence of non-communicable diseases and access to care among non-camp Syrian refugees in northern Jordan. Conflict and health. 2018;12:1–14. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Alefan Q, Al-Issa ET, Alzoubi KH, Hammouri HM. Association of smoking with direct medical expenditures of chronic diseases in north of Jordan: a retrospective cohort study. BMJ open. 2019;9(10):e031143. doi: 10.1136/bmjopen-2019-031143 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Alghadir A, Alghwiri AA, Awad H, Anwer S. Ten-year diabetes risk forecast in the capital of Jordan: Arab Diabetes Risk Assessment Questionnaire perspective—A strobe-complaint article. Medicine. 2016;95(12). doi: 10.1097/MD.0000000000003181 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Jamee Shahwan A, Abed Y, Desormais I, Magne J, Preux PM, Aboyans V, et al. Epidemiology of coronary artery disease and stroke and associated risk factors in Gaza community–Palestine. PloS one. 2019;14(1):e0211131. doi: 10.1371/journal.pone.0211131 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Mohammad Nazzal. Alshloul AMK. Hypertension among Faculty Members of Health Sciences College at South Saudi Arabia: Prevalence and Risk Factors 2016 [145–50].
  • 29.Sulaiman N, Elbadawi S, Hussein A, Abusnana S, Madani A, Mairghani M, et al. Prevalence of overweight and obesity in United Arab Emirates Expatriates: the UAE national diabetes and lifestyle study. Diabetology & metabolic syndrome. 2017;9(1):1–9. doi: 10.1186/s13098-017-0287-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Kalavathy R, Al Araj SA, Rabbani SA. Prevalence of obesity among adults in Ras Al Khaimah, United Arab Emirates. Int J Res Med Sci. 2019;7:555. [Google Scholar]
  • 31.Abu-Helalah MA, Alshraideh HA, Al-Serhan A-AA, Nesheiwat AI, Da’na M, Al-Nawafleh A. Epidemiology, attitudes and perceptions toward cigarettes and hookah smoking amongst adults in Jordan. Environmental Health and Preventive Medicine. 2015;20(6):422–33. doi: 10.1007/s12199-015-0483-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Jaghbir M, Shreif S, Ahram M. Pattern of cigarette and waterpipe smoking in the adult population of Jordan. EMHJ-Eastern Mediterranean Health Journal. 2014;20(9):529–37. [PubMed] [Google Scholar]
  • 33.Beni Yonis O, Saadeh R, Chamseddin Z, Alananzeh H. Exercise counseling by primary care physicians in Jordan—a preliminary study. Journal of Primary Care & Community Health. 2020;11:2150132720946947. doi: 10.1177/2150132720946947 [DOI] [PMC free article] [PubMed] [Google Scholar]

Decision Letter 0

Ala'a B Al-Tammemi

18 Mar 2024

PONE-D-24-06204Prevalence of and factors associated with chronic diseases among university academics in JordanPLOS ONE

Dear Dr. Khamaiseh,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by May 02 2024 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Ala'a B. Al-Tammemi, MD, MPH

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at 

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Please update your submission to use the PLOS LaTeX template. The template and more information on our requirements for LaTeX submissions can be found at http://journals.plos.org/plosone/s/latex.

3. We note that your Data Availability Statement is currently as follows: [All relevant data are within the manuscript and its Supporting Information files.]

Please confirm at this time whether or not your submission contains all raw data required to replicate the results of your study. Authors must share the “minimal data set” for their submission. PLOS defines the minimal data set to consist of the data required to replicate all study findings reported in the article, as well as related metadata and methods (https://journals.plos.org/plosone/s/data-availability#loc-minimal-data-set-definition).

For example, authors should submit the following data:

- The values behind the means, standard deviations and other measures reported;

- The values used to build graphs;

- The points extracted from images for analysis.

Authors do not need to submit their entire data set if only a portion of the data was used in the reported study.

If your submission does not contain these data, please either upload them as Supporting Information files or deposit them to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. For a list of recommended repositories, please see https://journals.plos.org/plosone/s/recommended-repositories.

If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially sensitive information, data are owned by a third-party organization, etc.) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent. If data are owned by a third party, please indicate how others may request data access.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: No

Reviewer #3: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Suggestions

1. I suggest to edit the title as follow: Prevalence and Associated Factors of Chronic Diseases Among University Academics in Jordan.

2. Line 146: The term "subjects" may not be appropriate in this context, as it can imply a level of passivity. Consider using "Participants" or "Study Participants" for clarity and to maintain professionalism.

3. Line 162: Provide more detail about the self-administered structured questionnaire, such as the number of questions, response options, and any specific chronic diseases addressed. This will enhance the understanding of the instrument's content and relevance to the study.

4. Line 174: Specify the qualifications and expertise of the professional translator who translated the questionnaire into Arabic to ensure accuracy and reliability in the translation process.

5. Line 202: Specify whether the written consent form provided to participants was available in both Arabic and English to accommodate diverse language preferences among the academic staff.

COMMENT 1: Although the study mentions the participation of a majority of faculty members, it is crucial to include specifics about the sample size and the proportion of faculty members who were approached but declined to participate. Furthermore, the study should address whether the sample accurately represents the broader academic population at Mutah University.

COMMENT 2: The specified timeline for data collection (February 5 to March 5, 2023) provides clarity regarding the study's duration. However, it would be beneficial to discuss any considerations regarding seasonal variations or academic schedules that could impact participant availability or response rates during this period.

COMMENT 3: The discussion underscores significant gender disparities in smoking prevalence, noting a higher percentage of male participants reporting smoking compared to females. However, it would be beneficial to explore the underlying reasons for these disparities further, taking into account factors such as cultural norms, social attitudes towards smoking, and gender-specific health behaviors.

Reviewer #2: Thank you for the opportunity to review your good work. However, every review brings comments to improve the work. Please consider the following comments:

Lines 50-53: The two sentences in lines 50-53 might be redundant. Please review them.

Lines 64-67: This part includes a long confusing sentence that needs to be rewritten.

Lines 76-77: A reference is needed for the following sentence “Despite the widespread belief that university academics generally maintain good health”.

Lines 96-98: the sentence is lengthy, unclear, and includes a new abbreviation NCDs!

Lines 106-110: Thesis-like summary at the end of the introduction is undesirable.

Lines 111-117: Subtitles under the research questions are not needed. Be more concise and just mention the research questions.

Lines 118-122: Once again, a thesis-like summary is not appropriate in research articles.

Methods

Line 131: Do we need to know the area of the university, does it matter?

Lines 132-137: Instead of mentioning the faculties by name, it is worth noting that classifying faculties into health and non-health faculties might bring up some significant and more meaningful differences.

Lines 138-145: This paragraph introduces extra information about students, better to remove.

General comments:

Although the researchers studied academics in Jordan who are apparently older than 40 years old, the introduction introduces the prevalence of chronic diseases among young people. The introduction needs to be enriched with more information and statistics about NCCDs among older people.

Throughout the manuscript, the researchers keep mentioning chronic diseases despite introducing the NCCDs term at the beginning of the introduction. Can you use the term NCCDs instead of just repeating the names of chronic diseases?

Methods:

Did you use a priori or post hoc analysis to estimate the sample size? Doing so is necessary to draw valid conclusions.

Results:

Line 240: Suddenly, a new term (Pain) was introduced! This is very far from the study's aims.

More data analysis is needed, the current results display just descriptive statistics.

Table 1: it was mentioned in the methodology that both Jordanian and Non-Jordanian academics were included in the study. However, table 1 doesn't show this classification.

Subheadings under the results are preceded by unnecessary words (part1, part2, and part 3).

Did you follow the STROBE checklist in reporting your research? Please add it as a supplementary file.

The quality of figure one is poor, a new figure with high resolution is needed to be produced. Reference list: Mistakenly, a full stop appears before the number of each reference.

Reviewer #3: Dear Authors,

Thank you for your efforts in conducting a very interesting manuscript. Please take all of these comments and recommendations into consideration in your decision to enhance the paper, as follows:

1- The discussion identifies a high prevalence of regular walking among academic staff, attributing it to awareness of the importance of physical activity in preventing chronic diseases. While this interpretation is plausible, further discussion on potential barriers to physical activity among academic staff, such as time constraints or work-related stress, would provide a more nuanced understanding of the findings.

2- The discussion briefly mentions the importance of maintaining a healthy body weight and engaging in regular physical activity to prevent chronic diseases. However, offering specific recommendations for future research directions and interventions aimed at promoting health and reducing the prevalence of chronic diseases among academic staff would enhance the discussion's practical implications.

3- It is noted that specific items in the questionnaire are subjective and rely on each participant's individual opinions. While subjectivity in questionnaire items is common, it's essential for researchers to acknowledge this limitation and consider potential biases introduced by subjective responses.

4- The implications could explore how the study findings could be integrated into the nursing education curriculum to prepare future nurses for addressing chronic diseases in community settings.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

Reviewer #3: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2024 Aug 13;19(8):e0304829. doi: 10.1371/journal.pone.0304829.r002

Author response to Decision Letter 0


8 Apr 2024

I have thoroughly examined all the feedback provided by the reviewers, and I am confident that my response adequately addresses their comments.

Attachment

Submitted filename: Response to Reviewers.doc

pone.0304829.s004.doc (62KB, doc)

Decision Letter 1

Ala'a B Al-Tammemi

23 Apr 2024

PONE-D-24-06204R1Prevalence and Associated Factors of Non-communicable chronic diseases Among University Academics in Jordan.PLOS ONE

Dear Dr. Khamaiseh,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Jun 07 2024 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Ala'a B. Al-Tammemi, MD, MPH

Academic Editor

PLOS ONE

Additional Editor Comments:

1- Many paragraphs of the manuscript seem like AI-Assisted Language/writing, please confirm if AI software was used or not.

2- The manuscript needs extensive English language editing.

3- Line 95-100: Rephrase the sentence without using first person pronouns

4- Lines 104 – 126: I do not understand the rationale behind these sections as they both contains repetitive information which was already provided in the introduction

5- Study instruments: The authors explain that they adopted the Sample Questionnaire for Chronic Disease from Stanford Patient Education Research Center. Did the author use part or all the questionnaire items? The authors should clarify this fact and they have to explain to the readers the operationalization of the only items used or adopted from the questionnaire to avoid confusion.

How did the authors measure BMI to identify obesity vs overweight? Did the survey include body weight and height? Also, why alcohol use was not examined as it is a potential risk factor? Also, how did the author define regular walking? Any criteria?

6- Discussion Section: While comparing the findings with regional studies, are the comparison between countries involves studies among academics? Comparing your study findings which is a single-center study among academics with other regional studies that involve various study populations will not be reliable. Please modify the discussion to compare your findings with regional or international studies that examined NCCDs among academic staff.

7- Limitations: Line 423-424: Better to be omitted

8- Implications: Unfortunately, the implications provided do not match the overall objective of the study. Why would the authors direct the implications toward nurses’ education only? I know that this was respectfully suggested by one of the reviewers, however, discuss in this section the potential consequences, recommendations, or practical applications of research findings without specifying nurses’ roles per se.

9- The authors are attaching the Stanford Survey only. Please provide the survey that the authors formulated to collect the data in this study for replicability and not the Stanford questionnaire (as it is already available publicly).

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

Reviewer #2: (No Response)

Reviewer #3: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Dear Dr,

I have carefully revised the commentary provided in the response file and thoroughly reviewed the revised manuscript. I am pleased to inform you that all the comments and suggestions provided have been diligently addressed and incorporated into the updated version. Therefore, I believe that no further revisions or comments are necessary at this time.

Thank you for your time and guidance throughout this process. I am confident that the manuscript is now ready for publication.

Best regards,

Reviewer #2: Thank you for addressing most of the concerns and comments I raised. However, the article still lacks for the STROBE checklist with proper citation.

Reviewer #3: I appreciate all of your hard work. It appears that every suggestion and comment was taken into consideration.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Nour Amin Elsahoryi

Reviewer #2: No

Reviewer #3: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2024 Aug 13;19(8):e0304829. doi: 10.1371/journal.pone.0304829.r004

Author response to Decision Letter 1


4 May 2024

I express my sincere gratitude to the editor for his insightful comments. I'm hoping my responses to them will be acceptable and persuasive.

Attachment

Submitted filename: Response to reviewrs 2-5-2024.doc

pone.0304829.s005.doc (40KB, doc)

Decision Letter 2

Ala'a B Al-Tammemi

20 May 2024

Prevalence and Associated Factors of Non-communicable chronic diseases Among University Academics in Jordan.

PONE-D-24-06204R2

Dear Dr. Abdullah Mousa Khamaiseh

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. If you have any questions relating to publication charges, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Ala'a B. Al-Tammemi, MD, MPH

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Dear Dr.Abdullah Mousa Khamaiseh,

Thank you for this hard work and for addressing all the reviewers' and academic editor's comments.

Best regards

Reviewers' comments:

Acceptance letter

Ala'a B Al-Tammemi

3 Jun 2024

PONE-D-24-06204R2

PLOS ONE

Dear Dr. Khamaiseh,

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team.

At this stage, our production department will prepare your paper for publication. This includes ensuring the following:

* All references, tables, and figures are properly cited

* All relevant supporting information is included in the manuscript submission,

* There are no issues that prevent the paper from being properly typeset

If revisions are needed, the production department will contact you directly to resolve them. If no revisions are needed, you will receive an email when the publication date has been set. At this time, we do not offer pre-publication proofs to authors during production of the accepted work. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few weeks to review your paper and let you know the next and final steps.

Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

If we can help with anything else, please email us at customercare@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Ala'a B. Al-Tammemi

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 File. Stanford patient education questionnaire.

    (PDF)

    pone.0304829.s001.pdf (150.6KB, pdf)
    S2 File. Arabic study questionnaire.

    (DOC)

    pone.0304829.s002.doc (93KB, doc)
    S3 File. English Study questionnaire.

    (DOC)

    pone.0304829.s003.doc (155.5KB, doc)
    Attachment

    Submitted filename: Response to Reviewers.doc

    pone.0304829.s004.doc (62KB, doc)
    Attachment

    Submitted filename: Response to reviewrs 2-5-2024.doc

    pone.0304829.s005.doc (40KB, doc)

    Data Availability Statement

    All relevant data are within the manuscript and its Supporting information files.


    Articles from PLOS ONE are provided here courtesy of PLOS

    RESOURCES